Induction Chemotherapy Combined With Camrelizumab in Locoregionally Advanced Hypopharyngeal Cancer
Status:
Recruiting
Trial end date:
2022-12-12
Target enrollment:
Participant gender:
Summary
The study is a single center phase II trial. The purpose is to investigate both the efficacy
and safety of chemotherapy combined with anti-PD-1 antibody Followed by chemoradiotherapy in
locoregionally advanced hypopharyngeal cancer.